🔗 Share this article

A shadow market for unapproved slimming medications is being driven by social media fitness personalities and vendors on messaging platforms, based on new investigations.

Experimental Treatment Gaining Popularity Online

Retatrutide, which remains in research studies, is being advertised by social media influencers for its alleged weight-reducing properties. Viewers are encouraged to contact these profiles directly for supplier links, while also receiving promotional offers.

Thriving Commerce on Messaging Platforms

Separately, a robust market exists on Telegram, where groups with thousands of members share comparison images, injection guides and assertions of rapid British shipping. Vendors market the drug there before redirecting customers to other platforms for purchases.

Learning About Retatrutide

This medication is an investigational injectable created by US drugmaker Eli Lilly. The drug targets three intestinal hormones – glucagon-like peptide-1, GIP and pancreatic hormone. Preliminary studies suggest it could assist individuals lose up to 25% of their body weight. Nicknamed the “triple G”, the substance is being hailed digitally as the successor to Ozempic.

Healthcare Experts Express Concerns

However, physicians and chemists have warned that the distribution of what remains an unapproved drug in the United Kingdom is a cause for concern and could result in individuals administering substances of uncertain source.

Some experts stated the popularity for the experimental drug could be connected to the rising cost of licensed slimming products such as Mounjaro.

Regulatory Position and Enforcement

Selling retatrutide on social media or messaging apps is illegal in the United Kingdom, as it is an unapproved drug that cannot be marketed or supplied for personal consumption under the British medical regulations.

Some influencers try to circumvent the rules by referring to the drug as a “research chemical” or citing it as “not for human consumption”. Retatrutide is not a restricted drug, but promotion and supply can still breach pharmaceutical, marketing, and customer laws, potentially leading to penalties, prosecution or prison.

Platform Reaction and Material Elimination

Based on TikTok, the platform has taken down problematic material and prohibited associated keywords and search suggestions. The organization said it was committed to keeping the platform secure and allocating resources in strengthening compliance measures.

Digital Trading Activities

Research also found communities with up to 9,000 participants marketing retatrutide using Telegram's built-in discovery tool, which functions like a public directory. Typing “retatrutide” immediately displays channels with thousands of users, populated with images of slimming results, positive reviews and step-by-step guides for mixing or injecting at home.

Within moments of joining one group, a vendor posted WhatsApp details, where most transactions take place. The vendor sent an instruction manual and guaranteed shipping within 48 hours. When questioned whether the substance was authentic, one vendor responded: “You can’t be sure.” Another shared a image of a supposed testing documentation. Not one asked about body mass, medical conditions or previous experience.

Item Information and Costs

Within these groups, posts show black plastic packages with Royal Mail stickers, stating to include fresh supplies. One communication stated: “It took eight of us to load them this morning.”

Buyers can choose between powder vials, mixed at home with purified liquid, or ready-to-use pens typically sold at 160 pounds for 20 milligrams. When asked how long a pen should last, vendors give contradictory responses ranging from a several days to “depends on your body”.

Service Moderation and Security Actions

A representative for the messaging service stated it actively moderated dangerous content on its service including material that promoted the “misuse of controlled medications”. The organization added that it removed “millions of pieces of harmful content each day”.

Healthcare Professional Cautions

“People are injecting substances they can’t verify. Although the science behind this drug is valid, these digital versions may not include what they claim,” said a pharmacy expert, the head of pharmaceutical services at Chemist4U.

A medical professional of Asda Online Doctor linked the increase in demand to recent cost increases for authorized weight-loss drugs such as Mounjaro. “With prices rising, individuals are using online platforms. But fake treatments are highly risky. You can’t be certain what’s inside or whether the environment they were produced in was sterile,” she explained.

Her team has already seen individuals injured by personal administration from unverified sources. “We understand the frustration, but buying from Telegram or WhatsApp is gambling with your well-being,” said the doctor. “These materials could be impure or incorrectly dosed.”

Manufacturer Position

A spokesperson from Eli Lilly said retatrutide was in phase 3 clinical trials and had not been evaluated or approved by any regulatory agency anywhere in the world. “Consequently at this time no one can sell [it] for personal consumption,” they explained, noting that any item “misleadingly claiming itself as a company investigational product not yet approved … may expose users to possibly significant health risks”.